Aquisição do medicamento Mirvetuximab soravtansina 5 mg/ml Sol inj Fr 20 ml IV - AE

ID 11991848 · Portal BASE
Price
Base Price
€31,554 .00
Effective Price
€31,554 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ABBVIE, LDA
NIF 510229050
Company
Dates
Publication
01 Dec 2025
Celebration
15 Nov 2025
Contracting Entity
Unidade Local de Saúde de Santo António, EPE
NIF 517392259
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
745
Supplier
123
Number of Awards
8
Rule
A1 repeat direct award: 8 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
01 Dec 2025
Signing Date
15 Nov 2025
Days Late
16
Rule
A2/A3 late publication: 16 days after signing (threshold: 10)
Detected 2026-03-06